Nicholas Company Inc. Buys 3,890 Shares of Novanta Inc. $NOVT

Nicholas Company Inc. boosted its stake in shares of Novanta Inc. (NASDAQ:NOVT) by 8.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 48,239 shares of the technology company’s stock after acquiring an additional 3,890 shares during the quarter. Nicholas Company Inc. owned approximately 0.13% of Novanta worth $5,740,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in NOVT. Pilgrim Partners Asia Pte Ltd acquired a new position in Novanta during the 3rd quarter valued at about $36,000. Migdal Insurance & Financial Holdings Ltd. acquired a new position in Novanta during the 3rd quarter valued at about $40,000. Danske Bank A S acquired a new position in Novanta during the 3rd quarter valued at about $40,000. Farther Finance Advisors LLC lifted its position in Novanta by 1,291.4% during the 4th quarter. Farther Finance Advisors LLC now owns 487 shares of the technology company’s stock valued at $58,000 after purchasing an additional 452 shares during the period. Finally, Assetmark Inc. lifted its position in Novanta by 22.4% during the 4th quarter. Assetmark Inc. now owns 541 shares of the technology company’s stock valued at $64,000 after purchasing an additional 99 shares during the period. Institutional investors own 98.35% of the company’s stock.

Analysts Set New Price Targets

NOVT has been the topic of a number of research reports. Robert W. Baird upgraded shares of Novanta from a “neutral” rating to an “outperform” rating and cut their target price for the company from $150.00 to $144.00 in a research report on Monday, March 30th. Zacks Research upgraded shares of Novanta from a “strong sell” rating to a “hold” rating in a research report on Friday, January 16th. Weiss Ratings restated a “hold (c-)” rating on shares of Novanta in a research report on Friday, April 17th. Finally, Wall Street Zen downgraded shares of Novanta from a “buy” rating to a “hold” rating in a research report on Saturday, April 18th. One equities research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $144.00.

Insider Activity at Novanta

In other Novanta news, CEO Matthijs Glastra sold 6,500 shares of the firm’s stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $130.05, for a total transaction of $845,325.00. Following the sale, the chief executive officer directly owned 56,761 shares in the company, valued at approximately $7,381,768.05. This trade represents a 10.27% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Robert Buckley sold 9,957 shares of the firm’s stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $116.77, for a total transaction of $1,162,678.89. Following the sale, the chief financial officer owned 96,616 shares in the company, valued at $11,281,850.32. This trade represents a 9.34% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 25,380 shares of company stock worth $3,296,276 over the last 90 days. Corporate insiders own 1.20% of the company’s stock.

Novanta Stock Performance

Shares of NOVT stock opened at $138.31 on Monday. The company has a debt-to-equity ratio of 0.16, a quick ratio of 2.80 and a current ratio of 3.69. The company has a market capitalization of $4.93 billion, a P/E ratio of 94.73 and a beta of 1.62. The company’s 50 day moving average price is $125.83 and its two-hundred day moving average price is $125.05. Novanta Inc. has a 52 week low of $98.27 and a 52 week high of $149.95.

Novanta (NASDAQ:NOVT) last announced its earnings results on Monday, February 23rd. The technology company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.88 by $0.03. The firm had revenue of $258.35 million for the quarter, compared to the consensus estimate of $260.72 million. Novanta had a net margin of 5.49% and a return on equity of 13.12%. During the same period last year, the company posted $0.76 EPS. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. On average, analysts expect that Novanta Inc. will post 3.54 earnings per share for the current fiscal year.

Novanta Company Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.